SOHM Inc (SHMN)

[john12341]

you are wrong

C. Describe the issuers’ principal products or services, and their markets
Services Provided by SHMN, and their Markets
SHMN develops and commercializes generic pharmaceuticals, utilizing its controlled-release and other in-house
and formulation technologies. The Company focuses on developing generic versions of brand-name products for
which the patents are near expiration or expired and requiring a proprietary formulation expertise. By innovating
processes, and applied innovation, the Company’s proprietary processes and formulation skills allow it to develop
generic versions that replicate the brand-name products’ physiological effects but don’t infringe on any valid
patents.

The Company actively reviews pharmaceutical patents and seeks opportunities to challenge patents it believes
are either invalid or would not be infringed by a generic version. SHMN also enters into collaboration, alliances
and partnerships to acquire rights to pharmaceuticals it does not own and to share development costs or resolve
patent barriers to entry. Overall, the Company’s generic product development strategy leverages a legal strategy
predicated on non-infringement of established brand name pharmaceuticals and speed of filing and also provide
applied innovation.

The Company has a manufacturing license of generic pharmaceuticals and currently produces and markets
generic pharmaceutical products along with dermatology and Nutraceutical products. The classification and
industry position allows for a significant increase in profit margins and scalability of manufacturing operations.
This license provides SHMN the production infrastructure to operate as a corporate manufacturing hub located
in India for the production and export of generic pharmaceuticals.

CORPORATE OVERVIEW
The Company’s strategic manufacturing facility in an area considered one of the safest and perfect for pharmaceutical
operations. The facility is approximately 5,500 square feet. In February 2009, SHMN’s manufacturing facility was
licensed by the India FDA. The license indicates compliance with Current Good Manufacturing Practice (CGMP)
Regulations: Division of Manufacturing and Product Quality and compliant with World Health Organization (WHO)
regulations and FDA.

The manufacturing facility provides complete technical support for production activities and houses the following:

? A third-party quality control laboratory with instruments to provide, chemical and microbiological analytical
support; to provide constant in process checks

? A spacious raw materials storage area which provides separate storage facilities for incoming materials,
quarantine materials, released materials and a separate section for sampling under controlled environment and
isolated areas for dispensing of raw materials; through documented SOPs for stringent control systems of checks
and balances.

? A finished goods warehouse for storage and distribution of finished good


source page 10

https://backend.otcmarkets.com/otcapi/company/financial-report/283247/content